Loading…
H.R. 4993119th Congress
Official title: Joe Fiandra Access to Home Infusion Act of 2025
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
Medicare would cover home infusion pumps and drugs needing professional administration if given by a qualified provider.
45-second read · 4 questions answered below
This bill lets Medicare cover home infusion equipment and drugs even when a health care professional must give or supervise the drug, as long as a qualified home infusion provider handles it safely. The drug must be infused at least 12 times a year via IV, under the skin, or at a pump-controlled rate. HHS would also need to ensure patients are told about cost differences between home and other treatment settings.
This affects Medicare beneficiaries needing regular infusion treatments, including those with chronic illnesses, immune disorders, or infections requiring long-term IV medication. It also affects home infusion therapy companies and health care professionals providing these services.
More patients could qualify for home-based infusion coverage instead of receiving treatment in a hospital or clinic setting. This shifts where and how infusion therapy services are delivered and paid for under Medicare.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
Latest action: — Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 0.